News At The University of Kansas Cancer Center

Grant Advances Ovarian Cancer Early Detection Efforts

Researchers at The University of Kansas Cancer Center have received a three-year, $900,000 grant from the Ovarian Cancer Research Alliance (OCRA) to better understand why epithelial ovarian cancers take decades to develop as well as identify methods...

Dec 30, 2019

Grants and Funding, Research & Innovation, Ovarian Cancer

News

New Prognostic Markers Guide Triple-Negative Breast Cancer Treatment Decisions

Triple-negative breast cancer is unique because it lacks estrogen receptors, progesterone receptors and excess HER2 protein – the drivers of other breast cancer subtypes. It is more aggressive and has a poorer prognosis, primarily because there are f...

Dec 18, 2019

Breast Cancer, Women's Health, Research & Innovation

News

Protein Overexpression Tied to Pancreatic Cancer

A preclinical study led by researchers at The University of Kansas Cancer Center has identified a potential new target in the treatment of pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Their findings were published in G...

Dec 16, 2019

Pancreatic Cancer, Research & Innovation

News

Andrew Godwin Named Recipient of Higuchi Biomedical Sciences Award

Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and professor and director of Molecular Oncology in the department of Pathology and Laboratory Medicine at the University of Kansas Medical Center, has been awarded a Higuc...

Dec 06, 2019

Accolades & Awards, Cancer Biology

News

International Society of Gastrointestinal Oncology Appoints Weijing Sun, President-Elect

The International Society of Gastrointestinal Oncology (ISGIO), a not-for-profit global educational organization committed to gastrointestinal oncology, announced that Weijing Sun, MD, FACP, has been elected the society’s next leader. Dr. Sun serves...

Dec 05, 2019

Announcements, Bladder Cancer, Stomach Gastric Cancer

News

Ciclomed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle Invasive Bladder Cancer Patients

First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients. Kansas City, MO – December 4, 2019 – CicloMed LLC...

Dec 04, 2019

Clinical Trials , Bladder Cancer, Clinical Trials

News

Cancer Center Team Members, Partners Recognized

Each year, The University of Kansas Cancer Center hosts its Research Symposium, convening experts to collaborate and discuss advances in cancer research. As part of Research Symposium activities, members and partners of the cancer center are recogniz...

Nov 26, 2019

Accolades & Awards

News

Midwest Cancer Alliance Changes Name to Masonic Cancer Alliance

In recognition of a significant contribution made by the Kansas Masons to support efforts to prevent cancer and improve people's lives, the Midwest Cancer Alliance is now the Masonic Cancer Alliance. The name change from Midwest Cancer Alliance to Ma...

Nov 15, 2019

Announcements

News

Grant Establishes Gynecologic Cancer Patient Mentor Program

A $60,000 grant from the Ovarian Cancer Research Alliance (OCRA) will help launch a novel peer-to-peer mentoring program at The University of Kansas Cancer Center for women diagnosed with gynecologic cancers. The support program, called Woman to Woma...

Nov 11, 2019

Gynecologic Cancer, Grants and Funding, Women's Health

News

Priyanka Sharma Awarded Grant by Mary Kay Foundation

Priyanka Sharma, MD, breast oncologist at The University of Kansas Cancer Center, was awarded a $100,000 grant from The Mary Kay Foundation to advance research efforts on targeted therapy for metastatic breast cancer. Despite clinical advances, 40,00...

Nov 07, 2019

Breast Cancer, Grants and Funding, Treatments and Therapies

News

Pilot Study Identifies Effects of Bazedoxifene and Conjugated Estrogen on Breast Cancer Risk Biomarkers in High Risk Women

Researchers at The University of Kansas Cancer Center have identified an agent that improves risk biomarkers for breast cancer while reducing menopausal side effects in women at increased risk for breast cancer. Chemoprevention drugs like tamoxifen c...

Oct 25, 2019

Breakthroughs and Innovation, Breast Cancer

News

Ronald Chen, MD, MPH, Named Chair of Radiation Oncology

Ronald Chen, MD, MPH, has been named the Brandmeyer Chair and Professor of Radiation Oncology at the University of Kansas School of Medicine, clinical service chief at The University of Kansas Health System and associate director for Health Equity at...

Sep 20, 2019

Announcements, Radiation Therapy, Our Cancer Center

News

PIVOT Member Named to Komen Advocates in Science Program

Kim Jones, a member of The University of Kansas Cancer Center’s Patient and Investigator Voices Organizing Together (PIVOT) program, has been named a Komen Advocate in Science (AIS). After being diagnosed with breast cancer in 2012, Jones devoted her...

Sep 17, 2019

Announcements, African American , Breast Cancer

News

KU Cancer Center Receives Grant to Expand Clinical Trials in Rural Kansas

The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas’ rural communities. The six-year grant designates the team as a minority/underserved (MU) community s...

Sep 09, 2019

Grants and Funding, Health Disparities , Outreach

News

Team Aims to Close Rural-Urban Cancer Survival Gap

While people in rural areas across the U.S. are less likely than urban dwellers to be diagnosed with cancer, they are more likely to die from it. A multidisciplinary team of researchers from The University of Kansas Cancer Center has received a five-...

Aug 27, 2019

Rural , Outreach, Cancer

News Releases

Grant Advances Ovarian Cancer Early Detection Efforts

New Prognostic Markers Guide Triple-Negative Breast Cancer Treatment Decisions

Protein Overexpression Tied to Pancreatic Cancer

Andrew Godwin Named Recipient of Higuchi Biomedical Sciences Award

International Society of Gastrointestinal Oncology Appoints Weijing Sun, President-Elect

Ciclomed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle Invasive Bladder Cancer Patients

Cancer Center Team Members, Partners Recognized

Midwest Cancer Alliance Changes Name to Masonic Cancer Alliance

Grant Establishes Gynecologic Cancer Patient Mentor Program

Priyanka Sharma Awarded Grant by Mary Kay Foundation

Pilot Study Identifies Effects of Bazedoxifene and Conjugated Estrogen on Breast Cancer Risk Biomarkers in High Risk Women

Ronald Chen, MD, MPH, Named Chair of Radiation Oncology

PIVOT Member Named to Komen Advocates in Science Program

KU Cancer Center Receives Grant to Expand Clinical Trials in Rural Kansas

Team Aims to Close Rural-Urban Cancer Survival Gap

Explore more news, events and blog